SCHEMBL12790366

SCHEMBL12790366

CCN(CC)CCN(C(C)C)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
SIGMAR1 Q99720 1/20 0.31
TSHR P16473 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27857528 0.86 MEN1 (0.36) MEN1KMT2APOLB
SCHEMBL25777660 0.86 MEN1 (0.36) MEN1KMT2A
SCHEMBL17426972 0.84 MEN1 (0.53) MEN1KMT2A
SCHEMBL12790357 0.83 MEN1 (0.42) MEN1KMT2ASIGMAR1TSHR
SCHEMBL1133203 0.80 MEN1 (0.62) MEN1KMT2A
SCHEMBL8997704 0.79 MEN1 (0.71) MEN1KMT2ATSHR
SCHEMBL2845420 0.78 TSHR (0.32) TSHR
SCHEMBL232247 0.77 MEN1 (0.39) MEN1KMT2ASIGMAR1TSHRPOLB
SCHEMBL15052708 0.77 MEN1 (0.39) MEN1KMT2ASIGMAR1TSHRPOLB
SCHEMBL12672874 0.77 SIGMAR1 (0.31) MEN1KMT2ASIGMAR1TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11696953-B2 Poly(beta-amino esters) and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-07-11 US disclosed
US-20210388196-A1 GENE DELIVERY CARRIER MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-12-16 US disclosed
US-11041069-B2 Gene delivery carrier MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-06-22 US disclosed
US-20200172663-A1 POLYMER-LIPIDS AND COMPOSITIONS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2020-06-04 US disclosed
US-20190194444-A1 GENE DELIVERY CARRIER POLITECNICO DI MILANO (IT) 2019-06-27 US disclosed
US-20160009657-A1 AMINE-CONTAINING LIPIDS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2016-01-14 US disclosed
US-9006487-B2 Amine-containing lipids and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-04-14 US disclosed
US-20110052673-A1 THERAPEUTIC COMPOSITIONS SHIRE HUMAN GENETIC THERAPIES, INC. 2011-03-03 US disclosed
US-20110052673-A1 THERAPEUTIC COMPOSITIONS SHIRE HUMAN GENETIC THERAPIES, INC. 2011-03-03 US disclosed
US-20110009641-A1 Amine-containing lipids and uses thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194444-A1 GENE DELIVERY CARRIER PAICS, PBDC1, BCAT1 MEN1 3571/4885KMT2A 2017/4885SIGMAR1 4663/4885
US-20200172663-A1 POLYMER-LIPIDS AND COMPOSITIONS PHOSPHO1, PEBP1, PBDC1 MEN1 2959/4885KMT2A 2490/4885SIGMAR1 3959/4885
US-20110052673-A1 THERAPEUTIC COMPOSITIONS PHOSPHO1, SGMS1, APOB MEN1 718/4885KMT2A 2906/4885SIGMAR1 686/4885
US-11041069-B2 Gene delivery carrier PAICS, PBDC1, BCAT1 MEN1 3571/4885KMT2A 2017/4885SIGMAR1 4663/4885
US-20110009641-A1 Amine-containing lipids and uses thereof PHOSPHO1, CHMP4B, SGMS1 MEN1 1363/4885KMT2A 2031/4885SIGMAR1 887/4885
US-20210388196-A1 GENE DELIVERY CARRIER PAICS, PBDC1, BCAT1 MEN1 3571/4885KMT2A 2017/4885SIGMAR1 4663/4885
US-11696953-B2 Poly(beta-amino esters) and uses thereof BCAT1, BCAT2, SNRPE MEN1 4493/4885KMT2A 2481/4885SIGMAR1 1250/4885
US-20160009657-A1 AMINE-CONTAINING LIPIDS AND USES THEREOF PHOSPHO1, CHMP4B, SGMS1 MEN1 1363/4885KMT2A 2031/4885SIGMAR1 887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.